EQS News: LR Health & Beauty SE best Wachstums trend in the quarter 2024 Page 1

• Turnover rose to EUR 143.3 million in the first half of 2024
• Normalized EBITDA of EUR 14.4 million
• Increasing demand for subscription concepts such as the successful LR Health Mission
• Growth prospects boosted by innovative product range and planned launch of new product segment in September

Ahlen, August 30, 2024 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality health and beauty products, today published its figures for the second quarter of 2024 and the first half of 2024. In the second quarter of the 2024 financial year, LR Health & Beauty SE increased its sales (revenue from goods sold) by 2.6% to EUR 70.7 million (Q2 2023*: EUR 68.9 million). In the first half of the year, LR Health & Beauty SE thus generated sales of EUR 143.3 million (H1 2023*: EUR 140.9 million). New product launches, such as the LR Health Mission and the LR Body Mission, contributed significantly to the positive sales performance in the period.

In addition, LR Health & Beauty SE generated normalized EBITDA of EUR 14.4 million in the first six months of fiscal year 2024, compared to EUR 17.5 million in the same period of the previous year*. Earnings performance was impacted by factors such as refinancing costs in connection with the early redemption of the old bond of LR Global Holding GmbH and the issuance of a new bond by LR Health & Beauty SE, as well as negative currency effects. Reported EBITDA amounted to EUR 11.7 million in the first half of 2024, compared to EUR 15.4 million in the same period of the previous year*.